AlphAIAlphAI — Financial news for AI agents
stocktitan.net$PACS

PACS Group, Inc. Reports Third Quarter 2026 Results

PACS Group, Inc. reported Q3 2026 revenue of $14.50 billion, up 11.5% YoY, and net income of $52.3 million, up 16.2%. Adjusted EBITDA rose 33.6% to $131.5 million. Occupancy improved to 91.3% in SNFs. The company plans acquisitions and raised 2026 guidance for revenue and Adjusted EBITDA. PACS had $707.4 million in cash and $115.3 million in liquidity as of Q3 2026.

Original reporting
stocktitan.net
Published Nov 3, 2026, 9:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 9:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$PACS
Bullish
high confidence
Mentioned
$PACS
Relevance
7/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$PACSBullishMed
01

Why it matters

Higher guidance may attract growth‑oriented investors and support the stock price.

02

Market read

Earnings beat and guidance raise provide a fresh catalyst for PACS stock.

03

What to watch

Potential integration risks from recent acquisitions could temper upside.

Relevance 7/10Novelty 8/10Timing: today

Background

PACS Group, Inc. released its Q3 2026 earnings and raised its full‑year outlook.

Company-level read

Ticker impact

$PACSBullishHigh confidence
Context

Q3 2026 results posted with raised full-year Adjusted EBITDA and revenue guidance.

Expected impact

likely upside as investors price in higher earnings forecasts

Evidence & confidence

Guidance increase of double‑digit percentages signals improved profitability and growth, prompting buying pressure.

Market effects

Sector

Strong post‑acute care earnings may lift related healthcare REITs.

Regional

U.S. healthcare sector could see modest gains.

Global

Limited to U.S. investors; no broad macro effect.

Counterpoint

What could challenge this read

If guidance is already priced in, the stock may face a short‑term pullback.

Key entities

  • Company
    PACS Group, Inc.

    Post‑acute healthcare operator reporting earnings.

Read at source← All news

StoryPACS Group reports Q3 2026 results and lifts full‑year revenue and adjusted EBITDA outlook

Also covered by

4 outlets

Related articles

$PACSMedAI 8/10

What PACS Group (PACS) Said on Its Q3 Earnings Call

PACS Group reported 196 mature, 90 ramping, and 35 new skilled nursing facilities with occupancy ranging from 76.2% to 93.1%. The company acquired 32 Florida and 10 Texas skilled nursing operations post-quarter. PACS raised its 2026 revenue outlook to $5.95B-$6.05B and adjusted EBITDA to $685M-$695M, citing strength in existing operations and new acquisitions. Operating cash flow was $583.1M for the first nine months of 2026, with $707.4M in available liquidity.

finance.yahoo.com
$PACSHighAI 8/10

PACS Group Inc (PACS) (Q3 2026) Earnings Call Highlights: Revenue Tops

PACS Group Inc (NYSE:PACS) reported Q3 2026 revenue growth of 6.4%, with adjusted EBITDA up 33.6% to $175.7M. The company raised full-year guidance, citing strong occupancy and skilled mix improvements. PACS also highlighted a robust acquisition pipeline and integration plans for 31 Eduro facilities. Challenges include lower metrics at newly acquired facilities and ongoing government investigations.

finance.yahoo.com
$PACSHigh

Why is PACS stock surging today?

PACS Group Inc (PACS) stock rose 6.0% in after-hours trading after beating Q3 2026 earnings and revenue estimates. The company also raised its full-year 2026 Adjusted EBITDA and revenue guidance. Analysts maintain a 'Moderate Buy' rating with an average price target of $58.80. The surge was driven by company-specific news.

investing.com